GLP-1 receptor agonist: difference between revisions
Diff·revision 26 → 27·16:46, 6 Jul 2025
Difference between revision 26 and revision 27 of GLP-1 receptor agonist. 3 lines changed; the page grew by 164 bytes.
| Revision 26 — 14:50, 15 Jun 2025 IcodecIndra (talk) serial comma per PP:MOS 9,758 bytes ±0 | Revision 27 — 16:46, 6 Jul 2025 ComparisonCato (talk) copyedit 9,922 bytes +164 | ||
|---|---|---|---|
| 72 | * Müller TD, Finan B, Bloom SR, et al. "Glucagon-like peptide 1 (GLP-1)." ''Molecular Metabolism'' 30:72–130 (2019). | 72 | * Müller TD, Finan B, Bloom SR, et al. "Glucagon-like peptide 1 (GLP-1)." ''Molecular Metabolism'' 30:72–130 (2019). |
| 73 | 73 | ||
| + | 74 | == External links == | |
| + | 75 | * [https://clinicaltrials.gov/study/NCT03574597 SELECT — NCT03574597] — Registry record for the cardiovascular outcome trial cited above. | |
| + | 76 | ||
| 74 | == See also == | 77 | == See also == |
| 75 | * [[Glucagon-like peptide-1]] | 78 | * [[Glucagon-like peptide-1]] |